The expansion of pharmacy prescribing is being sold as convenient, modern, and patient-centred. But behind the messaging lies a more uncomfortable truth. This is a fundamental shift in how we define safe medical care, and it is happening without the level of scrutiny it deserves.
Prescribing is not a retail service. It is not a checklist. And it is not risk-free.
Yet that is exactly how it is being reframed.
Take the oral contraceptive pill often dismissed as ‘routine’. It is anything but that.
Safe prescribing requires identification of contraindications that are not always visible, not always disclosed, and not always understood by patients themselves.
Migraine with aura. Stroke risk. Thromboembolic disease. Cardiovascular risk. Drug interactions, to name a few. Miss one, and the consequences are real. This is where clinical judgement matters. Not protocols. Not algorithms. Because patients don’t walk in with perfectly packaged histories. They present with fragments. It is the clinician’s role to connect them.
A 16-year-old asking for the pill may not mention visual aura. She may not recognise it as relevant. She may not even be asked the right question in the right way. That gap between what is said and what needs to be known is where medicine happens.
And it is exactly what we risk losing. Because let’s call this what it is: a shift from clinical care to transactional care.
This is not reform. It is fragmentation dressed up as access.
When prescribing is detached from longitudinal care, we don’t just lose nuance, we lose opportunity.
The opportunity to screen for STIs.
The opportunity to initiate cervical screening.
The opportunity to identify coercion, violence, or mental health concerns.
The opportunity to intervene early.
These are not optional extras. They are core to women’s healthcare. And once gone, they’re not easily replaced.
